The Mycobacterium sp. BRS2A-AR2 is an endophyte of the mangrove plant Rhizophora racemosa G. Mey., which grows along the banks of the River Butre, in the Western Region of Ghana. Chemical profiling using 1 H-NMR and HRESI-LC-MS of fermentation extracts produced by the strain led to the isolation of the new compound, α-d-Glucopyranosyl-(1→2)-[6-O-(l-tryptophanyl)-βd-fructofuranoside] or simply tortomycoglycoside (1). Compound 1 is an aminoglycoside consisting of a tryptophan moiety esterified to a disaccharide made up of β-d-fructofuranose and α-d-glucopyranose sugars. The full structure of 1 was determined using UV, IR, 1D, 2D-NMR and HRESI-LC-MS data. When tested against Trypanosoma brucei subsp. brucei, the parasite responsible for Human African Trypanosomiasis in sub-Saharan Africa, 1 (IC 50 11.25 µM) was just as effective as Coptis japonica (Thunb.) Makino. (IC 50 8.20 µM). The extract of Coptis japonica (Thunb.) Makino. is routinely used as laboratory standard due to its powerful antitrypanosomal activity. It is possible that, compound 1 interferes with the normal uptake and metabolism of tryptophan in the T. brucei subsp. brucei parasite. very broad bioactivities because, part of their structures are composed of one or more stereocenter laden sugar portions with numerous hydroxyls and other functionalities that confer increased drug water solubility, increased bioavailability, decreased toxicity, effective drug targeting, bioactivity, strong molecular targeting and organism specificity while the non-sugar portion or aglycones, represent molecules that also have many bioactivities [17] . Glycosides have been shown to exhibit potent αand β-glucosidase inhibition (nojirimycin and acarbose) [18] [19] [20] , antibacterial (streptomycin, erythromycin A, vancomycin, gentamycin, amikacin, kanamycin, neomycin and bleomycin) [21-23], anticancer (digoxin and biselyngbyaside) [24, 25] , antifungal (hassallidin A and B, and macrolide CE-108) [26] [27] [28] , antiparasitic (amphotericin B and paromomycin) [29] [30] [31] [32] and antioxidant (floridoside) activities [33] . Biologically, carbohydrates are known to participate in energy storage and constitute a major component of structural polymers in microbes, plants and invertebrates [34] [35] [36] [37] . Furthermore, as a result of their structural and chemical characteristics, they play many other key biological roles such as fertilization signaling, pathogen recognition, cellular interactions and tumor metastasis [38] [39] [40] [41] . Therefore, it may be proposed that naturally occurring glycosides constitute a possible source of future antiparasitic, antitumor, antiviral, anticoagulant, antioxidant and anti-inflammatory drugs.
Introduction
Carbohydrate-based natural products constitute a very potent group of compounds with promising prospects as future drugs [1] . Currently, there are many carbohydrate natural product derived compounds that are already drugs and these include: The polysaccharides, tragacanth (diarrhea and constipation) [2] , astragalus (cancer) [3] , lentinan (cancer and hepatitis B) [4] , tremella (cancer and chronic bronchitis) [5, 6] , icodextrin (peritoneal dialysis) [7] and pentosan polysulfate (interstitial cystitis) [8] ; the oligosaccharides, lactulose (constipation and hepatic encephalopathy) [9] , sucralfate (active duodenal ulcers) [10] ; and the monosaccharides, miglitol (anti-diabetic) [11] and meglumine (excipient) [12] .
Glycosylated natural products are defined as natural compounds where the carbohydrate part (glycone), either monomers or oligomers of different structures, is covalently bound to another chemical structure (aglycone). The aglycone encompasses natural product scaffolds such as terpenes, steroids, alkaloids, ribosomal and non-ribosomal peptides, modified amino acids, polyketides, macrolides, flavonoids, polyenes, coumarins, anthracyclines, iridoids and lignans [13] [14] [15] [16] . Glycosides display strain is an endophyte of a mangrove plant that produced a very distinct 16S rRNA gene sequence, it has been safe to work with it so far.
Large scale culture of Mycobacterium sp. BRS2A-AR2 in ISP2 fermentation media at pH 5.0, 28 • C and 220 rpm produced extracts which upon solvent partitioning by a modification of Kupchan's method gave four fractions hexane (FH), dichloromethane (FD), methanol/water (FM) and butanol/water (WB). Phytochemical screening on thin-layer chromatography (TLC) plates using iodine tank, Dragendorff, phosphomolybdic acid, antimony (III) chloride and Ninhydrin reagents showed the WB to contain the most interesting metabolites. The fraction WB was therefore subjected to a Sephadex LH-20 size exclusion chromatography to give four fractions of which WB-SF4 was found to contain the compound of interest. HPLC of WB-SF4 led to the isolation of the potent glycoside antitrypanosomal compound (Figure 1 ), α-d-glucopyranosyl-(1→2)-[6-O-(l-tryptophanyl)-β-d-fructofuranoside] or simply tortomycoglycoside (1) (2.3 mg/L). The structure of this new compound was determined using a combination of 1D-and 2D-NMR techniques with high-resolution liquid chromatography tandem mass spectrometry (HRESI-LC-MS) data and TLCs.
Molbank 2019, 2019, x 4 of 11 gCOSY correlation H-5′/H-4′ along with the 2D-TOCSY correlations H-4′/H-3′, H-5′/H-3′, H-5′/H-4′, H-6′/H-3′ and H-6′/H-4′ confirmed the continuous spin system of the β-D-fructofuranose residue while the gHMBCAD correlations C-4′ to H-3′, C-5′ to H-3′, C-5′ to H-4′, C-1′ to H-3′ and C-6′ to H-4′ showed the positions of quaternaries and heteroatoms in the ring. The gHMBCAD correlation C-2′ to H-1′′ helped to solve the rest of the structure, which was shown to be an α-D-glucopyranose ring after similar examination of the sugar ring, which is explained above. The α-D-glucopyranose ring carbon chemical shifts were δC 91.8 (C-1′′), 71.7 (C-2′′), 72.8 (C-3′′), 69.9(C-4′′), 72.9 (C-5′′) and 60. 
Results
The to H-4, C-2, C-3, C-3a and C-7a to 1NH, C-3, C-3a and C-7a to H-2, C-3a, C-4 and C-5 to H-7, C-3a and C-7 to H-5 and finally C-4, C-5 and C-7a to H-6.
In the 13 C NMR spectrum, the presence of several peaks between 65-95 ppm suggested the presence of sugar moieties in compound (1) . The gHMBCAD correlations C-10 to H-5 and H-6 and the chemical shifts of C-10 and C-6' provided direct proof of attachment of the tryptophan residue to a sugar through an ester bond. The identities of the sugars were found to be β-d-fructofuranose and α-d-glucopyranose after inspection of the chemical shifts, anomeric coupling constants, 1 H-1 H Rotating-frame Overhauser Spectroscopy (ROESY) data, molecular modeled structure and chiral TLCs. Complete NMR data for Compound 1 is given in Table 1 while the raw data can be found in the Supplementary Figures S4-12 Complete NMR data for Compound 1 is given in Table 1 while the raw data can be found in the Supplementary Figures S4-12 Compound 1 showed very interesting and consistent results when tested against our laboratory strain of T. brucei brucei. The IC 50 value of 11.25 µM calculated for 1 was almost as effective as that of the routine laboratory standard Coptis japonica (IC 50 8.20 µM). Detailed examination of the dose response curve for 1 ( Figure 5 ) showed the potential for this compound to be significantly lethal and potent against T. brucei brucei cells.
Compound 1 showed very interesting and consistent results when tested against our laboratory strain of T. brucei brucei. The IC50 value of 11.25 µM calculated for 1 was almost as effective as that of the routine laboratory standard Coptis japonica (IC50 8.20 µM). Detailed examination of the dose response curve for 1 ( Figure 5 ) showed the potential for this compound to be significantly lethal and potent against T. brucei brucei cells.
It is possible that, compound 1 described herein can affect the easy recognition of the amino acid tryptophan within the extracellular matrix. Therefore, subsequent uptake of tryptophan, metabolism of tryptophan and the incorporation of tryptophan into important enzymes such as proteases and phospholipases that contribute to the normal functions of the T. brucei brucei parasite is perturbed [50, 51] . 
Experimental Section

General Experimental Procedures
1D and 2D NMR data were recorded on a Bruker AVANCE III HD Prodigy (BRUKER, Sylvenstein, Germany) at 500 and 125 MHz for 1 H and 13 C, respectively. This instrument was optimized for 1 H observation with pulsing/decoupling of 13 C and 15 N, with 2H lock channels equipped with shielded z-gradients and cooled preamplifiers for 1 H and 13 C. The 1 H and 13 C chemical shifts were referenced to the solvent signals (δH 2.50 (1H, p) and δC 39.52 ppm in DMSO-d6). Highresolution mass spectrometry data were measured using a ThermoScientific LTQXL-Discovery Orbitrap (Thermo Scientific, Bremen, Germany) coupled to an Accela UPLC-DAD system. The following conditions were used for mass spectrometric analysis: Capillary voltage 45 V, capillary temperature 320 °C, auxiliary gas flow rate 10-20 arbitrary units, sheath gas flow rate 40-50 arbitrary units, spray voltage 4.5 kV and mass range 100-2000 amu (maximum resolution 30,000). The ion It is possible that, compound 1 described herein can affect the easy recognition of the amino acid tryptophan within the extracellular matrix. Therefore, subsequent uptake of tryptophan, metabolism of tryptophan and the incorporation of tryptophan into important enzymes such as proteases and phospholipases that contribute to the normal functions of the T. brucei brucei parasite is perturbed [50, 51] .
Experimental Section
General Experimental Procedures
1D and 2D NMR data were recorded on a Bruker AVANCE III HD Prodigy (BRUKER, Sylvenstein, Germany) at 500 and 125 MHz for 1 H and 13 C, respectively. This instrument was optimized for 1 H observation with pulsing/decoupling of 13 C and 15 N, with 2H lock channels equipped with shielded z-gradients and cooled preamplifiers for 1 H and 13 C. The 1 H and 13 C chemical shifts were referenced to the solvent signals (δ H 2.50 (1H, p) and δ C 39.52 ppm in DMSO-d 6 ). High-resolution mass spectrometry data were measured using a ThermoScientific LTQXL-Discovery Orbitrap (Thermo Scientific, Bremen, Germany) coupled to an Accela UPLC-DAD system. The following conditions were used for mass spectrometric analysis: Capillary voltage 45 V, capillary temperature 320 • C, auxiliary gas flow rate 10-20 arbitrary units, sheath gas flow rate 40-50 arbitrary units, spray voltage 4.5 kV and mass range 100-2000 amu (maximum resolution 30,000). The ion source was normal electrospray ionization that acts both in positive and negative modes. Semi-preparative HPLC purifications were carried out using a Phenomenex Luna reverse-phase (C18 250 × 10 mm, L × i.d.) column connected to a Waters 1525 Binary HPLC pump Chromatograph with a 2998 photodiode array detector (PDA), column heater and in-line degasser. Detection was achieved on-line through a scan of wavelengths from 200 to 400 nm. This system was also used to record the UV profile for the compounds. IR was measured using a PerkinElmer FT-IR (UATR Two) spectrometer. All solvents were HPLC grade. Sephadex LH-20 and HP-20 resin were obtained from Sigma Aldrich (Munich, Germany).
Mangrove Plant Sample Collection
The Ghanaian mangrove plant R. racemosa was collected along the banks of the River Butre in the Western Region of Ghana at GPS coordinates: 4 • 49 43.73 N and 1 • 54 50.84 W elevation 7 m; eye altitude 437 m. The plant parts sampled were leaves, buds, submerged roots, aerial roots, aerial stems, fruit shoots and flowers.
Isolation and Purification of the Endophytic Mycobacterium Strain
Isolation, purification, identification and laboratory cultivation of the Ghanaian Mycobacterium sp. BRS2A-AR2 were previously described by us [42] .
Fermentation
An Autoclaved Erlenmeyer flask (250 mL) plugged with non-absorbent cotton wool containing 50 mL of ISP2 (10 g of malt extract, 4 g each of yeast extract and D-glucose) fermentation media in distilled water with pH 5.0 was directly inoculated with spores of strain BRS2A-AR2 and incubated at 28 • C and 220 rpm for three days. This seed culture was subsequently used to inoculate nine autoclaved 1 L Erlenmeyer flasks, each containing 200 mL ISP2 media at pH 5.0 and plugged with non-absorbent cotton wool. The 1 L flasks were incubated at 28 • C and 220 rpm for 21 days. Two days before the culture incubation period was complete, autoclaved HP-20 resin was added at 50 g/L to each of the flasks under sterile conditions and the flasks were returned to the incubator.
Extraction and Purification
The Mycobacterium sp. strain BRS2A-AR2 fermentation broth (1.8 L) was filtered through a piece of glass wool under suction in a Buchner funnel to separate the supernatant from the mycelia. The supernatant was extracted with EtOAc and the mycelia and HP-20 resin were placed in a 1 L flask and extracted first with CH 2 Cl 2 followed by MeOH. All extracts were combined and evaporated under reduced pressure to obtain a total crude extract (5.90 g). The total crude extract was subjected to a modification of Kupchan's solvent partitioning process [52] that gave the four fractions FH (1.2 g), FD (1.6 g), FM (0.50 g) and WB (2.3 g), with the compounds of interests concentrated in the FD and WB fractions. The Kupchan solvent partitioning process is able to simplify subsequent purification and isolation steps, chemical profiling and biological activity screening by separating the extract components according to their polarities. Briefly, the total crude extract was suspended in 200 mL of water and extracted three times over three consecutive days with CH 2 Cl 2 . The water layer was subsequently, extracted with sec-butanol once. The sec-butanol layer was dried under vacuum to give a butanol/water (WB) fraction and the remaining water layer discarded. The CH 2 Cl 2 layer was dried under vacuum and suspended in 90/10 mixture of water/methanol. The 90/10 water/methanol mixture was extracted three times over three consecutive days with hexane. The hexane extract was dried under vacuum to give fraction hexane (FH). The 90/10 water/methanol layer was phase adjusted to 50/50 water/methanol and extracted three times with dichloromethane. The dichloromethane layer was dried under vacuum to give fraction dichloromethane (FD). Drying the 50/50 water/methanol layer under vacuum gives fraction methanol/water (FM). The fraction FH is the least polar fraction whilst WB is the most polar fraction. The WB fraction was then subjected to Sephadex LH-20 size exclusion chromatography by gravity to obtain four fractions that were labeled WB-SF1-4. Phytochemical screening with ninhydrin on TLC plates followed by 1 H-NMR showed the compound of interest to be concentrated in the WB-SF4 (0.34 g). Fraction WB-SF4 was therefore subjected to semi-preparative HPLC separation and purification using a Phenomenex Luna C18 column (C18 250 × 10 mm, L × i.d.). Gradients of Solvent A: H 2 O (0.1% HCOOH) and Solvent B: CH 3 CN (0.1% HCOOH; 100% A to 100% B in 30 min and hold for 30 min) were used as eluents with column flow rates set at 1.5 mL/min to afford compound 1 (2.5 mg, t R = 20.0 min). Table 1 ; mass spectrometry data is detailed in Supplementary Figures S1 and S2. 
Acid Hydrolysis of Compound 1
Compound 1 (1.5 mg) was dissolved in MeOH (2 mL) and 5 N HCl (1 mL). The mixture was refluxed for 3 h. The solution was neutralized with NaOH, extracted with EtOAc and concentrated under vacuum. The sugars in the aqueous phase were identified as fructose and glucose by comparative TLC with standard sugars using the solvent system BuOH/EtOAc/2-propanol/HOAc/H 2 O (7:20:12:7:6). This acid hydrolysis further confirmed the identities of the two sugars present in the structure of compound 1. , gentamycin, penicillin-streptomycin-l-glutamine (PSG), artesunate, alamar dye, dimethyl sulfoxide (DMSO), sodium citrate, adenine, sodium bicarbonate (NaHCO 3 ), AlbuMax II, sodium chloride (NaCl), potassium chloride (KCl), sodium phosphate dibasic (Na 2 HPO 4 ), sodium phosphate monobasic (KH 2 PO 4 ) and sodium hydroxide (NaOH), were purchased from Sigma-Aldrich, MO, USA. All other chemicals and reagents were of analytical grade.
Bioassay Reagents
Compound Preparation for Bioassay
A stock solution of compound 1 was prepared at a concentration of 100 mM. This was achieved by drying the compound with nitrogen gas and weighing on a balance (AND GH-120, A and D Company Limited, Tokyo, Japan) to ascertain the mass of the compound. Compound 1 was dissolved in an appropriate amount of DMSO to attain the desired concentration. The stock solution was vortexed (MSI Minishaker. IKA Company, Osaka, Japan) and filter sterilized into a vial through 0.45 µm millipore filters under sterile conditions and stored at −20 • C until use.
Cell Culture
The GUTat 3.1 strain of the bloodstream form of T. brucei parasites was used in this study. Parasites were cultured in vitro according to the conditions established previously by Yabu et al. in 1998 [53] . Parasites were used when they reached a confluent concentration of 1 × 10 6 parasites/mL. Estimation of parasitemia was done with the Neubauer counting chamber. Parasites were diluted to a concentration of 3 × 10 5 parasites/mL with an IMDM medium and used for the drug assay.
In Vitro Viability Test for Trypanosome Parasites
The Alamar Blue assay was carried out on treated and untreated trypanosome parasites to ascertain their viability. The assay was performed in a 96-well plate following the manufacturer's instructions, with modification. Briefly, 1.5 × 10 4 parasites were seeded with varied concentrations of the compound ranging from 0 to 100 µM. Final concentrations of DMSO were kept at 0.1%. After the incubation of parasites with or without the compound for 24 h at 37 • C in 5% CO 2 , 10% Alamar Blue dye was added, and the parasites were incubated another 24 h in darkness. After a total of 48 h, the plate was read for absorbance at 540 nm using the Tecan Sunrise Wako spectrophotometer, AUSTRIA GmbH. The trend curve was drawn to obtain a 50% inhibitory concentration (IC 50 ) for the compound.
Conclusions
The Ghanaian Mycobacterium sp. BRS2A-AR2 (GenBank ID: KT945161) was previously isolated and characterized by our group from the aerial roots of the mangrove plant, R. racemosa. We also reported for the first time ever that, strain BRS2A-AR2 biosynthesizes gold nanoparticles that are cytotoxic to HUVEC and HeLa cell lines [42] . Herein we report that, the main metabolite produced in liquid culture by the strain BRS2A-AR2 is an amino acid glycoside (α-d-glucopyranosyl-(1→2)-[6-O-(l-tryptophanyl)-β-d-fructofuranoside]) that consists of a tryptophan moiety esterified to a disaccharide made up of β-d-fructofuranose and α-d-glucopyranose rings. Compound 1, exhibited potent antitrypanosomal effects when tested against the laboratory strain of T. brucei brucei. It is possible that, compound 1 interferes with the normal uptake and metabolism of tryptophan in the parasite.
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